Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Panacea Biotech Gains 5%; BSE HEALTHCARE Index Up 0.3%
Mon, 2 Dec 9:34

Panacea Biotech Gains 5%; BSE HEALTHCARE Index Up 0.3%Image source: ipopba/www.istockphoto.com

Panacea Biotech share price has zoomed 5% and is presently trading at Rs 469.2.

Meanwhile, the BSE HEALTHCARE index is at 43,781.9 (up 0.3%).

Among the top gainers in the BSE HEALTHCARE index today are ASTER DM HEALTHCARE (up 2.9%) and Natco Pharma (up 1.9%).

POLY MEDICURE (down 2.9%) and FORTIS HEALTHCARE (down 1.3%) are among the top losers today.

Over the last one year, Panacea Biotech has moved up from Rs 160.1 to Rs 469.2, registering a gain of Rs 309.1 (up 193.1%).

On the other hand, the BSE HEALTHCARE index has moved up from 29,654.9 to 43,781.9, registering a gain of 47.6% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 183.4%), SUVEN PHARMACEUTICALS (up 103.6%) and Glenmark Pharma (up 99.0%).

End of Year Sale: Save Rs 6,050 on our small cap research

What About the Benchmark Indices?

The BSE Sensex is at 79,340.7 (down 0.6%).

The top losers among the BSE Sensex today are Indusind Bank (down 1.4%) and HDFC Bank (down 1.1%). The most traded stocks in the BSE Sensex are Tata Steel and Tata Motors.

In the meantime, NSE Nifty is at 24,034.6 (down 0.4%). ONGC and HDFC LIFE INSURANCE are among the top losers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 66,174.2 to 79,340.7, registering a gain of 13,166.5 points (up 19.9%).

Panacea Biotech Financial Update...

Panacea Biotech net profit grew 156.8% YoY to Rs 47 million for the quarter ended September 2024, compared to a loss of Rs 83 million a year ago. Net sales rose 3.0% to Rs 1,474 million during the period as against Rs 1,430 million in July-September 2023.

For the year ended March 2024, Panacea Biotech reported 95.5% increase in net profit to Rs -15 million compared to net loss of Rs 337 million during FY23. Revenue of the company grew 21.6% to Rs 5,592 million during FY24.

The current Price to earnings ratio of Panacea Biotech, based on rolling 12 month earnings, stands at -187.1.


Equitymaster requests your view! Post a comment on "Panacea Biotech Gains 5%; BSE HEALTHCARE Index Up 0.3%". Click here!